跳至主要内容
临床试验/DRKS00021108
DRKS00021108招募中4 期

Cognitive function after liver transplantation comparing Tacrolimusformulations - CoFu-01

niversitätsklinikum Schleswig-Holstein Campus Kiel0 个研究点目标入组 150 人开始时间: 2020年11月11日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
20 Years 至 75 Years(—)
性别
All

入选标准

  • Written informed consent
  • - Age 20 to 75 years
  • - After 12 months post liver transplantation
  • - Immunosuppression with a twice daily formulation of Tacrolimus
  • - Application of the same active tacrolimus twice daily formulation since at least 3 months
  • - At least mild cognitive impairment

排除标准

  • - Dialysis treatment during the previous 30 days
  • - Defness and / or blindness
  • - Pregnancy / breastfeeding mothers
  • - Current participation in another study
  • - Every other aspect that, in the eye of the investigator, makes the patient unable to comply with study procedures
  • - Patients taking medications prohibited by the SmPC of Envarsus® and the currently pre-scribed twice daily formulation

研究者

发起方
niversitätsklinikum Schleswig-Holstein Campus Kiel

相似试验